Pulmonary function testing (PFT) is a vital diagnostic tool in respiratory medicine, providing a comprehensive evaluation of lung function. However, interpreting the results can be complex for healthcare professionals due to the plethora of data and the intricacies of lung physiology. This article aims to demystify the process of PFT interpretation.
Key parameters in PFT include Forced Vital Capacity (FVC), Forced Expiratory Volume in 1 second (FEV1), and the FEV1/FVC ratio. FVC reflects the maximum amount of air a patient can exhale forcefully after maximal inhalation, while FEV1 indicates the volume exhaled in the first second. The FEV1/FVC ratio is essential to distinguish between obstructive and restrictive lung disease.
A decreased FEV1/FVC ratio (<70%) indicates obstructive lung disease, such as asthma or COPD. In contrast, a restrictive pattern is suggested by a normal or increased FEV1/FVC ratio with reduced FVC. Conditions like pulmonary fibrosis and muscular dystrophy typically present this pattern.
Severity grading is based on the degree of reduction in FEV1. Mild obstruction is characterized by FEV1 ≥ 80% of the predicted value, moderate by 50-79%, severe by 30-49%, and very severe by <30%. In restrictive diseases, severity is often assessed by the degree of reduction in Total Lung Capacity (TLC).
Bronchodilator responsiveness testing can differentiate between asthma and COPD. A positive response, indicated by an increase in FEV1 or FVC by ≥12% and ≥200ml following bronchodilator administration, suggests asthma.
Interpreting PFT results is a nuanced process that requires understanding of lung physiology and the various parameters involved. By mastering these concepts, healthcare professionals can make accurate diagnoses, assess disease severity, and guide appropriate management of respiratory conditions.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation